Log In
Print
BCIQ
Print
Print this Print this
 

RG1662

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionNegative allosteric modulator of GABA A receptor alpha 5 (GABRA5)
Molecular Target GABA A receptor alpha 5 (GABRA5)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationCognitive dysfunction
Indication DetailsTreat cognitive and behavioral deficits associated with Down syndrome; Treat cognitive dysfunction associated with Down syndrome
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today